Interferon gamma up-regulates alpha 2 macroglobulin expression in human astrocytoma cells

J Neuroimmunol. 1994 Aug;53(1):31-7. doi: 10.1016/0165-5728(94)90061-2.

Abstract

An established human astrocytoma cell line (T67) was shown to constitutively produce the proteinase inhibitor alpha 2 macroglobulin (alpha 2M). Interferon gamma (IFN gamma), a potent immunoregulatory lymphokine, was able to increase the synthesis of alpha 2M by these cells, as measured by ELISA on cell supernatants. The alpha 2M induction was also observed in other human glioma cell lines (T70 and ADF) and in human fetal astrocyte cultures following IFN gamma treatment. In T67 cells this effect was dose-dependent and the maximum (2.7-fold increase) was obtained with 2000 U/ml of IFN gamma. A corresponding enhanced alpha 2M mRNA accumulation was demonstrated by PCR and Northern blot techniques. Our results suggest an important role of alpha 2M during inflammatory and immune processes in the CNS. An increased release of alpha 2M following IFN gamma stimulation may allow the removal of the bulk of proteases released at the site of inflammation, strengthening at the same time the antigen presentation processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Astrocytoma / metabolism*
  • Base Sequence
  • Humans
  • Interferon-gamma / pharmacology*
  • Molecular Sequence Data
  • RNA, Messenger / analysis
  • Tumor Cells, Cultured
  • Up-Regulation
  • alpha-Macroglobulins / biosynthesis*
  • alpha-Macroglobulins / genetics

Substances

  • RNA, Messenger
  • alpha-Macroglobulins
  • Interferon-gamma